The Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative global partnership launched in 2017, involving public, private, philanthropic, and civil society organizations. CEPI's mission is to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks. It funds promising vaccine candidates, supports clinical trials, and invests in new vaccine technologies and manufacturing capabilities. CEPI aims to make pandemics preventable by focusing on WHO-prioritized pathogens like Lassa fever, MERS, Nipah, and preparing for 'Disease X'.
The Oslo headquarters serves as the central nerve center for CEPI's global operations, driving strategic planning, scientific oversight, financial management, resource mobilization, and the coordination of its worldwide vaccine development programs and partnerships.
CEPI's Oslo office is situated in a modern office building designed to facilitate collaboration and efficient operations. The focus is on a functional and accessible workspace rather than specific architectural grandeur.
The work culture at CEPI HQ is dynamic, intensely mission-driven, and highly collaborative, reflecting its global team of experts. It's characterized by scientific rigor, a sense of urgency in addressing public health challenges, and a commitment to innovation and partnership.
Oslo provides a neutral and stable environment conducive to CEPI's global partnership model. Norway is a founding investor and a strong proponent of global health, making Oslo an ideal base for an organization of CEPI's nature.
CEPI's global presence is defined by its extensive network of partnerships and funded projects spanning multiple continents. It supports vaccine development with research institutions, biotech companies, and manufacturers worldwide. Key functions supported globally include strategic investments in vaccine R&D, oversight of international clinical trials, fostering innovation in vaccine platforms (like mRNA technology), building manufacturing capabilities, and championing equitable access to vaccines, particularly for low- and middle-income countries. This is achieved through its diverse international team and collaborations in regions critical for epidemic preparedness.
Marcus Thranes gate 2
Oslo
Oslo
Norway
Address: The Epworth, 25 City Road, London, EC1Y 1AA, UK
Facilitates critical collaborations in Europe, a key hub for scientific innovation, pharmaceutical development, and global health funding and policy.
Address: 1200 18th Street NW, Suite 700, Washington, DC 20036, USA
Essential for engaging with major global health funders, regulatory bodies, policymakers, and the significant biotech and pharmaceutical sectors in North America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cepi' leadership includes:
Cepi has been backed by several prominent investors over the years, including:
CEPI's core executive leadership team has demonstrated stability over the past 12 months (June 2023 - June 2024). One notable internal role evolution involved Aurélia Nguyen taking on the position of Chief Programme Officer. No major new external hires into, or departures from, the top-tier executive team have been widely publicized during this period.
Discover the tools Cepi uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CEPI's professional email addresses are expected to follow a common corporate structure, typically combining names with the '@cepi.net' domain. The most probable format is [first].[last]@cepi.net.
[first].[last]@cepi.net
Format
richard.hatchett@cepi.net
Example
85%
Success rate
CEPI News • June 18, 2024
CEPI announced a partnership with the University of Cambridge and DIOSynVax, providing up to US$19.3 million to advance an mRNA vaccine candidate against Rift Valley fever through preclinical studies, Phase I/II trials, and manufacturing process establishment....more
CEPI News • May 21, 2024
CEPI and the Indian Council of Medical Research (ICMR) have formed a partnership to advance the development of Nipah virus vaccines in India, leveraging local research and manufacturing capabilities to combat this deadly pathogen....more
CEPI News • April 25, 2024
CEPI issued a Call for Proposals seeking to fund the development of vaccine candidates against Henipaviruses (Nipah and Hendra viruses) utilizing innovative rapid response vaccine platforms to enhance global preparedness....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cepi, are just a search away.